Stockscreener 앱 받기
4.895
0.72%
0.035
시간 외 거래:
4.91
0.015
+0.31%
Sellas Life Sciences Group Inc 주식(SLS)의 최신 뉴스
SELLAS Life Sciences Group Inc. (SLS) Making Progress on Key Acute Myeloid Leukemia Treatment - Insider Monkey
SELLAS Life Sciences Group (SLS) price target increased by 26.83% to 8.84 - MSN
SELLAS Life Sciences (SLS) to present SLS009 data at AACR 2026 - MSN
Patterns Watch: Is SELLAS Life Sciences Group Inc trading at a discountQuarterly Growth Report & AI Powered Market Entry Strategies - baoquankhu1.vn
Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15% - MSN
SLS Stock Rises Premarket Ahead Of Cancer Summit This Month – Investors Eye Phase 3 AML Trial Milestone - Stocktwits
SLS Forecast, Price Target & Analyst Ratings | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill
Rally Mode: Can SELLAS Life Sciences Group Inc stock double in the next year2026 Valuation Update & Fast Moving Market Watchlists - baoquankhu1.vn
SLS stock rises premarket ahead of cancer summit this month – investors eye phase 3 AML trial milestone - MSN
Stock List: Research Stocks from Around the World - GuruFocus
History Review: Will SELLAS Life Sciences Group Inc benefit from seasonality2026 Levels & Daily Entry Point Trade Alerts - baoquankhu1.vn
Fed Watch: Whats the beta of SELLAS Life Sciences Group Inc stock2026 Analyst Calls & Daily Chart Pattern Signals - baoquankhu1.vn
SELLAS Rallies on Bullish Patterns — Despite Analyst Skepticism and Weak Fundamentals - Bitget
Levels Update: Is SELLAS Life Sciences Group Inc forming higher highs and higher lows2026 Year in Review & Verified Technical Signals - baoquankhu1.vn
SELLAS Life Sciences Group Stock Jumps 9.5% - National Today
SLS Technical Analysis | Trend, Signals & Chart Patterns | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill
Stock Report: Will SELLAS Life Sciences Group Inc benefit from green energy policies2026 Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
FRA:RXK3 PB Ratio: 9.04 — 66% Above Median - GuruFocus
SLS stock rallies ahead of AML trial readout — 'Pharma Bro' Martin Shkreli says he's still 'very bearish,' predicts drug will fail - MSN
SELLAS Life Sciences Group Stock Price Drops 7.7% - National Today
Gainers Report: Whats next for SELLAS Life Sciences Group Inc stock2026 Highlights & Low Risk Growth Stock Ideas - baoquankhu1.vn
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 7.7%Here's Why - MarketBeat
Why SELLAS Life Sciences Group (SLS) Is Down 8.3% After US$150 Million ATM Offering News - simplywall.st
SLS stock jumps overnight: ‘potent’ AML drug data ahead of cancer summit fuels fresh momentum - MSN
Sellas Life Sciences Secures Shelf Registration to Bolster Financial Flexibility - timothysykes.com
Wall Street Analysts Believe SELLAS Life Sciences Group, Inc. (SLS) Could Rally 63.58%: Here's is How to Trade - MSN
A Look At SELLAS Life Sciences Group (SLS) Valuation After SLS009 Data And New Equity Offering Plans - simplywall.st
SELLAS Life Sciences (SLS) to Present SLS009 Data at AACR 2026 - Insider Monkey
MACD Signal: Is SELLAS Life Sciences Group Incs ROIC above industry average2026 Price Targets & Smart Investment Allocation Tips - baoquankhu1.vn
Vanguard (SLS) files amendment showing 0% beneficial ownership (warrants disclosed) - Stock Titan
5 Popular Penny Stocks on Robinhood to Buy - Insider Monkey
All you need to know about SELLAS Life Sciences Group, Inc. (SLS) rating upgrade to buy - MSN
All Essential Information Regarding SELLAS Life Sciences Group, Inc. (SLS) Rating Raised to Buy - Bitget
All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy - Yahoo Finance
SELLAS Life Sciences Group Inc (SLS) Stock News & Articles - 24/7 Wall St.
2.69%
0.25%
자본화:
|
볼륨(24시간):